Author:
de Botton S,Sanz M A,Chevret S,Dombret H,Martin G,Thomas X,Mediavilla J D,Recher C,Ades L,Quesnel B,Brault P,Fey M,Wandt H,Machover D,Guerci A,Maloisel F,Stoppa A M,Rayon C,Ribera J M,Chomienne C,Degos L,Fenaux P
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Reference31 articles.
1. Fenaux P, Chevret S, Guerci A, Fegueux N, Dombret H, Thomas X et al. Long-term follow-up confirms the benefit of all-trans retinoic acid in acute promyelocytic leukemia. European APL group. Leukemia 2000; 14: 1371–1377.
2. Tallman MS, Andersen JW, Schiffer CA, Appelbaum FR, Feusner JH, Woods WG et al. All-trans retinoic acid in acute promyelocytic leukemia: long-term outcome and prognostic factor analysis from the North American Intergroup protocol. Blood 2002; 100: 4298–4302.
3. Mandelli F, Diverio D, Avvisati G, Luciano A, Barbui T, Bernasconi C et al. Molecular remission inPML/RAR-positive acute promyelocytic leukemia by combined all-trans retinoic acid, idarubicin (AIDA) therapy. Blood 1997; 90: 1014–1021.
4. Sanz MA, Martin G, Rayon C, Esteve J, Gonzalez M, Diaz-Mediavilla J et al. A modified AIDA protocol with anthracycline-based consolidation results in high antileukemic efficacy and reduced toxicity in newly diagnosed PML/RARalpha-positive acute promyelocytic leukemia. PETHEMA group. Blood 1999; 94: 3015–3021.
5. Fenaux P, Chastang C, Chevret S, Sanz M, Dombret H, Archimbaud E et al. A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. The European APL Group. Blood 1999; 94: 1192–2000.
Cited by
142 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献